DALLAS, TX, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) ...

An update from Cloudbreak Pharma, Inc. ( ($HK:2592) ) is now available. Cloudbreak Pharma has announced that its wholly owned U.S. subsidiary, ADS ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

IN/SCRUTABLE: Are lighter eyes easier to read or too much to bear? By Krista Madsen Last week I had fun going to the dark ...

Drug developers secured approvals for 46 new therapeutic agents from the FDA’s Center for Drug Evaluation and Research (CDER) in 2025. This cohort brings the 5-year average down a touch, to 48 new ...

The costs of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the drugmakers pledging to offer more favorable prices under new Trump ...

Venezuelan President Nicolás Maduro said he is open to talks with the United States on drug trafficking, oil and migration issues amid weeks of an escalating pressure campaign by the Trump ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results from the positive Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating the ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration ...

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even ...